March 2025 exceptional surveillance of suspected cancer: recognition and referral (NICE guideline NG12)
We reviewed the evidence and plan to update the non-specific symptoms relating to unexplained weight loss.
Surveillance decision
We will update the recommendation on non-specific symptoms relating to unexplained weight loss and highlight the need to refer patients according to age categories (recommendation 1.13.2).
This page was last updated: